Innovation
3 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 9 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
Investor mix
7 investors on record; lead investors include Frontline BioVentures, Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 86% |
| Other / undisclosed | 1 | 14% |